Continuing Medical Education 5th Annual Breast/Gynecologic Cancer Conference

在异质性的本质上，癌症的管理呈现出复杂的临床问题，需要不断发展的多学科方法来诊断和治疗。由于医学研究的快速步伐，新方法和信息的传播已被委托给国家癌症研究所指定的癌症中心，至少部分如此。作为这项R13拨款提案的主题的一系列多学科会议旨在通过审查癌症患者多学科管理的当前进展水平和未来方向来满足这一需求。这些主题是根据以前在希望之城举行的教育会议上的与会者所表达和证明的需求来选择的。知识差距是通过分析先前记录的对医生的信息请求来确定的。会议的教育形式将包括讲座、问答环节和案例介绍，通过使用电子观众反应系统进行互动观众参与。向服务于服务不足人群的从业者传播信息的成功与否，将通过问卷调查和南加州特定地理区域的医生和从业者出诊情况的相互关系来确定。鉴于乳腺癌、卵巢癌和宫颈癌的发生频率以及乳腺癌和卵巢癌的高死亡率，迫切需要开发新的治疗范例来优化患者的结果。在过去的几十年里，希望之城的科学家和医生们一直致力于推进诊断和治疗这些癌症的新技术。该节目由多学科科学家和医生团队主持，将回顾和评论乳腺癌、卵巢癌和宫颈癌治疗的现状、前沿发展和未来方向。重要的课题包括对HPV和宫颈癌发病率的研究。

Heterogeneous in nature the management of cancer presents complex clinical problems, requiring an ever evolving multi-disciplinary approach to diagnosis and treatment. Because of the rapid pace of medical research, the dissemination of new approaches and information has been delegated, at least in part, to National Cancer Institute Designated Cancer Centers. The series of multi-disciplinary conferences which is the subject of this R13 grant proposal has been designed to meet this need through the review of the current level of progress and the future directions in the multidisciplinary management of patients with cancer. The topics have been chosen based on expressed and demonstrated needs of previous attendees at educational conferences presented at the City of Hope. Knowledge gaps are determined through analysis of previously documented requests for information from physicians. The conference educational formats will include lectures, Q & A sessions, and case presentations with interactive audience participation thru the use of an electronic audience response system. Determination of the success in the dissemination of information to practitioners serving underserved populations will be determined through questionnaires and correlation of physician and practitioner attendance from specific geographic regions of Southern California. Given the frequency of occurrence of breast, ovarian and cervical cancers and the high mortality rate from breast and ovarian cancers, there is an urgency to develop new treatment paradigms to optimize patient outcomes. Over the past decades, scientist and physicians at City of Hope have devoted their efforts to advancing new techniques to diagnose and treat these cancers. Presented by a team of multidisciplinary scientist and physicians, this program will review and critique the current status, leading-edge developments and future direction in the treatment of breast, ovarian and cervical cancers. Important topics include research on HPV and the incidence of cervical cancer.